EWP Time to assess

Time to Assess

The US is making progress in getting control of this global pandemic that has affected our lives significantly. COVID-19 cases are still high, but hospitalizations and deaths are declining. Our experience shows that we still need to pursue the activities…

Monoclonal Antibody Treatments

Let’s Prevent Hospitalizations and Consider Monoclonal Antibody Treatments In November, 2020, FDA issued Emergency Use Authorizations (EUA) for two monoclonal antibody products. An EUA is different than full FDA approval in that it is issued in emergent circumstances, usually without…

Alternative Care Sites

As the SARS-CoV2 virus has surged across the US in the last month, EWP has seen increasing pressure on hospitals who are hard pressed to accommodate patients due to limitations in staff, space, and equipment. Although many facilities have invoked…